Selective serotonin reuptake inhibitors and suicidality: A guide for the perplexed

Canadian Journal of Psychiatry

Volumn 54, Issue 2, 2009, Pages 72-74

  Brent, David A ^a,b,c  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; FLUOXETINE; LIOTHYRONINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR;

ADOLESCENT HEALTH; ANXIETY; CAUSAL ATTRIBUTION; CHILD HEALTH; COGNITIVE THERAPY; DEPRESSION; DRUG HALF LIFE; DRUG RESPONSE; DRUG SAFETY; GROUPS BY AGE; HUMAN; PATIENT EDUCATION; PATIENT MONITORING; PRESCRIPTION; PRIMARY MEDICAL CARE; PSYCHOTHERAPY; RISK BENEFIT ANALYSIS; SHORT SURVEY; SUICIDAL BEHAVIOR; SUICIDAL IDEATION; SUICIDE;

EID: 60849127256     PISSN: 07067437     EISSN: 14970015     Source Type: Journal    
DOI: 10.1177/070674370905400202     Document Type: Short Survey

References (10)

1. Bridge J, Iyengar S, Salary CB, et al. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials. JAMA. 2007;297:1683-1696.
2. Hammad TA, Laughren T, Racoosin J. Suicidality in pediatric patients treated with antidepressant drugs. Arch Gen Psychiatry. 2006;63:332-339.
3. Libby A, Brent DA, Morrato EH, et al. Decline in treatment of pediatric depression after FDA advisory on risk of suicidality with SSRIs. Am J Psychiatry. 2007;164:884-891.
4. Olfson M, Shaffer D, Marcus SC, et al. Relationship between antidepressant medication treatment and suicide in adolescents. Arch Gen Psychiatry. 2003;60:978-982.
5. Emslie G, Kratochvil C, Vitiello B, et al. Treatment for Adolescents with Depression Study (TADS): safety results. J Am Acad Child Adolesc Psychiatry. 2006;45:1440-1455.
6. The TADS Team. The Treatment for Adolescents with Depression Study (TADS): long-term effectiveness and safety outcomes. Arch Gen Psychiatry. 2007;64:1132-1144.
7. Brent DA, Emslie GJ, Clarke GN, et al. Switching to venlafaxine or another SSRI with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized control trial. JAMA. 2008;299:901-913.
8. Rutz W. Mental health in Europe: problems, advances and challenges. Acta Pedaetr Scand. 2001;410:15-20.
9. Olfson M, Marcus SC. A case-control study of antidepressants and attempted suicide during early phase treatment of major depressive episodes. J Clin Psychiatry. 2008;69:425-432.
10. Simon GE, Savarino J, Operskalski B, et al. Suicide risk during antidepressant treatment. AmJ Psychiatry. 2006;163:41-47.